Total amount: € 0,00
Auclin C. F., Rat P., Tuil E., Boureau-Andrieux C., Morel C., Laplace O., Cambourieu C., Limon S., Nordmann J.-P., Laroche L., Baudouin C.
1 Reparto di Oftalmologia 3, Centro Ospedaliero Nazionale di Oftalmologia di Quinze-vingts 28, Parigi, Francia
2 Reparto di Farmacia e Sterilizzazione, Centro Ospedaliero Nazionale di Oftalmologia di Quinze-vingts 28, Parigi, Francia
3 Reparto di Oftalmologia 4, Centro Ospedaliero Nazionale di Oftalmologia di Quinze-vingts 28, Parigi, Francia
4 Reparto di Oftalmologia 2, Centro Ospedaliero Nazionale di Oftalmologia di Quinze-vingts 28, Parigi, Francia
5 Reparto di Oftalmologia 5, Centro Ospedaliero Nazionale di Oftalmologia di Quinze-vingts 28, Parigi, Francia
Aim. The aim of this monocentric, randomized, comparative, open study was to evaluate the safety of Amukine® 0.06%* solution (an isotonic hypochloride sodium solution) versus a 5% povidone iodine solution (Betadine® 5% for ocular irrigation) in antisepsis before cataract surgery.
Methods. One hundred and thirteen patients, aged between 49 and 90 years, were included and split, after randomization, into two groups: one testing Amukine® 0.06%, the other testing a 5% povidone iodine solution. For each group, after local anesthesia, the antiseptic procedure consisted of an antisepsis of periocular teguments followed by an eye antisepsis through the instillation of two drops of the tested product in the conjuntival fornices. The safety evaluation was performed by grading superficial punctuate keratitis 24 hours after surgery (slit lamp examination after fluorescein instillation).Conjunctival hyperemia scores by examination of the bulbar conjunctiva before the first instillation, immediately before surgery, and 24 hours after surgery were also compared.
Results. One hundred and seven reports were analyzed. Concerning the presence of corneal superficial punctuate keratitis 24 hours after surgery, mean scores were not different (0.27 for test). The observations did not show a different progression of conjunctival hyperemia depending on the treatment group (P=0.065, immediately after application) and P=0.52 (after 24 hours; Mann-Whitney test).
Conclusion. In this study, the ocular safety of Amukine® 0.06% solution was not different from a 5% povidone iodine solution. Therefore, Amukine® 0.06% solution is a new interesting approach to surgical antisepsis in ophthalmology and an alternative in case of iodine allergy.